Fox Run Management L.L.C. bought a new stake in shares of ZimVie Inc. (NASDAQ:ZIMV – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 33,199 shares of the company’s stock, valued at approximately $463,000. Fox Run Management L.L.C. owned approximately 0.12% of ZimVie at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp lifted its stake in shares of ZimVie by 0.9% during the fourth quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company’s stock worth $1,404,000 after purchasing an additional 943 shares in the last quarter. Rhumbline Advisers raised its holdings in shares of ZimVie by 3.0% during the 4th quarter. Rhumbline Advisers now owns 45,214 shares of the company’s stock valued at $631,000 after buying an additional 1,303 shares during the period. SG Americas Securities LLC lifted its position in ZimVie by 15.7% during the 4th quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock worth $155,000 after acquiring an additional 1,508 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in ZimVie by 9.8% in the 4th quarter. Principal Financial Group Inc. now owns 19,054 shares of the company’s stock worth $266,000 after acquiring an additional 1,702 shares during the period. Finally, Monarch Capital Management Inc. grew its position in ZimVie by 6.2% in the fourth quarter. Monarch Capital Management Inc. now owns 65,560 shares of the company’s stock valued at $915,000 after acquiring an additional 3,847 shares in the last quarter. 95.63% of the stock is owned by hedge funds and other institutional investors.
ZimVie Trading Up 2.1 %
Shares of ZIMV opened at $11.73 on Wednesday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. ZimVie Inc. has a one year low of $11.32 and a one year high of $22.40. The stock has a 50-day moving average price of $13.23 and a 200 day moving average price of $14.13. The company has a market capitalization of $324.65 million, a P/E ratio of -0.89 and a beta of 2.10.
Analyst Ratings Changes
Separately, Needham & Company LLC reissued a “hold” rating on shares of ZimVie in a research report on Thursday, March 13th.
Get Our Latest Report on ZimVie
About ZimVie
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Further Reading
- Five stocks we like better than ZimVie
- How to Invest in the FAANG Stocks
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- What is a Stock Market Index and How Do You Use Them?
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- 3 Warren Buffett Stocks to Buy Now
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.